The future is finally here: Advances in the treatment of atopic dermatitis - 21/02/18
Key word : atopic dermatitis
Publication of this article was supported by Leo Pharma, Bayer, and Sanofi/Regeneron. |
|
Funding sources: Supported by Bayer, LEO Pharma, and Sanofi. |
|
Disclosure: Dr Zirwas MD, has served on speakers' bureaus for Regneron, Sanofi, and Genentech. He has received compensation for consulting for Regeneron, Sanofi, and Valean and provided contract research for LEO Pharma, Regeneron, Janssen, Incyte, Foamix, Sanofi, and UCB Biopharma. |
Vol 78 - N° 3S1
P. S25-S27 - mars 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?